Patents by Inventor Tye Jensen
Tye Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12357662Abstract: Various embodiments of the present invention are directed to the field of treating and preventing osteoporosis, with particular embodiments directed to a method of ameliorating, treating, or preventing osteoporosis in a human subject employing tomatidine, xylitol, rapamycin, etc., as well as modifying an individual's microbiome to reduce the likelihood of osteoporosis.Type: GrantFiled: March 25, 2024Date of Patent: July 15, 2025Assignee: Seed Health, Inc.Inventors: Tye Jensen, Joseph E. Kovarik
-
Patent number: 12246043Abstract: Compositions, systems and methods of improving the health of the microbiome of an individual's skin relate to the provision of skin contacting formulations containing beneficial bacteria and other microbe components to foster the growth and maintenance of a healthy skin microbiome. Embodiments include methods for treating an individual suffering from acne valgaris by topically administering a composition that includes live bacteria selected from the group consisting of L. reuteri, L. johnsonii, L. crispatus, C. acnes, and Nitrosomonas eutropha, that have been modified by using a using a clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR associated protein (Cas) system or a CRISPR from Prevotella and Francisella 1 (Cpf1) system to reduce the production of a virulence factor of the bacteria.Type: GrantFiled: December 11, 2023Date of Patent: March 11, 2025Assignee: Seed Health, Inc.Inventors: Tye Jensen, Joseph E. Kovarik, Raja Dhir
-
Publication number: 20240366687Abstract: A method to reduce the likelihood of a dysbiosis of the vaginal microbiome in an individual employing a probiotic method and composition for maintaining a healthy vaginal microbiome, with particular embodiments including a bacterial formulation of three distinct species of Lactobacillus crispatus bacteria. In certain embodiments, the bacterial formulation is administered to an individual's vagina in an amount sufficient for the bacterial formulation to generate an amount of tryptophan metabolites sufficient to act as aryl hydrocarbon receptor (AHR) agonists, thereby reducing inflammation in the individual's vagina.Type: ApplicationFiled: June 10, 2024Publication date: November 7, 2024Applicant: Seed Health, Inc.Inventors: Sheri Simmons, Tye Jensen, Joseph E. Kovarik
-
Publication number: 20240277780Abstract: Various embodiments of the present invention are directed to the field of treating and preventing osteoporosis, with particular embodiments directed to a method of ameliorating, treating, or preventing osteoporosis in a human subject employing tomatidine, xylitol, rapamycin, etc., as well as modifying an individual's microbiome to reduce the likelihood of osteoporosis.Type: ApplicationFiled: March 25, 2024Publication date: August 22, 2024Applicant: Seed Health, Inc.Inventors: Tye Jensen, Joseph E. Kovarik
-
Patent number: 12005085Abstract: A method to reduce the likelihood of a dysbiosis of the vaginal microbiome in an individual employing a probiotic method and composition for maintaining a healthy vaginal microbiome, with particular embodiments including a bacterial formulation of at least two live bacteria selected from the group consisting of L. reuteri, L johnsonii and L. crispatus, and at least one prebiotic having glycogen as a component thereof. The bacterial formulation is administered to an individual's vagina in an amount sufficient for the bacterial formulation to generate an amount of tryptophan metabolites sufficient to act as aryl hydrocarbon receptor (AHR) agonists, thereby reducing inflammation in the individual's vagina. Certain embodiments include increasing the production of SCFAs in the individual's gut microbiome, while reducing the production of SCFAs in the individual's vagina and introducing ammonia oxidizing microorganisms to the individual's vagina.Type: GrantFiled: August 10, 2023Date of Patent: June 11, 2024Assignee: Seed Health, Inc.Inventors: Sheri Simmons, Tye Jensen, Joseph E. Kovarik
-
Patent number: 11998479Abstract: A method and system to address the adverse effects on an individual's oral microbiome with the objective of restoring gingival health caused by exposure to sodium lauryl sulfate. Certain embodiments of the present invention facilitate the growth of desired bacteria in a human's mouth to reduce the likelihood of dental caries, halitosis, canker sores, and other oral diseases. Probiotic bacterial, bioactive flavonoid, xylitol and zinc compound compositions, provide effective prevention and treatment options, especially while precluding the use of sodium lauryl sulfate so as to reduce adverse consequences it has on gingival health.Type: GrantFiled: August 16, 2023Date of Patent: June 4, 2024Assignee: Seed Health, Inc.Inventors: Sheri Simmons, Tye Jensen, Joseph E. Kovarik
-
Patent number: 11998574Abstract: Compositions, systems and methods of improving the health of the microbiome of an individual's skin relate to the provision of skin contacting formulations containing beneficial bacteria, postbiotics, metabolites and other microbe components to foster the growth and maintenance of a healthy skin microbiome. One embodiment includes a topical application of Lactobacillus crispatus to ameliorate skin barrier damage and inflammation using unique combinations of probiotics, prebiotics, postbiotics, and other skin-beneficial ingredients, effectively treating inflammatory skin diseases, such as atopic dermatitis, psoriasis and acne, through the production of tryptophan metabolites that act as AHR agonists.Type: GrantFiled: August 18, 2023Date of Patent: June 4, 2024Assignee: Seed Health, Inc.Inventors: Sheri Simmons, Tye Jensen, Raja Dhir, Joseph E. Kovarik
-
Publication number: 20240156878Abstract: Compositions, systems and methods of improving the health of the microbiome of an individual's skin relate to the provision of skin contacting formulations containing beneficial bacteria and other microbe components to foster the growth and maintenance of a healthy skin microbiome. Embodiments include methods for treating an individual suffering from acne valgaris by topically administering a composition that includes live bacteria selected from the group consisting of L reuteri, L johnsonii, L crispatus, C. acnes, and Nitrosomonas eutropha, that have been modified by using a using a clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR associated protein (Cas) system or a CRISPR from Prevotella and Francisella 1 (Cpf1) system to reduce the production of a virulence factor of the bacteria.Type: ApplicationFiled: December 11, 2023Publication date: May 16, 2024Applicant: Seed Health, Inc.Inventors: Tye Jensen, Joseph E. Kovarik, Raja Dhir
-
Patent number: 11951140Abstract: Various embodiments of the present invention are directed to the field of treating and preventing osteoporosis, with particular embodiments directed to a method of ameliorating, treating, or preventing osteoporosis in a human subject employing tomatidine, xylitol, rapamycin, etc., as well as modifying an individual's microbiome to reduce the likelihood of osteoporosis.Type: GrantFiled: May 4, 2023Date of Patent: April 9, 2024Assignee: Seed Health, Inc.Inventors: Tye Jensen, Joseph E. Kovarik
-
Publication number: 20240024378Abstract: Compositions, systems and methods of improving the health of the microbiome of an individual's skin relate to the provision of skin contacting formulations containing beneficial bacteria, postbiotics, metabolites and other microbe components to foster the growth and maintenance of a healthy skin microbiome. One embodiment includes a topical application of Lactobacillus crispatus to ameliorate skin barrier damage and inflammation using unique combinations of probiotics, prebiotics, postbiotics, and other skin-beneficial ingredients, effectively treating inflammatory skin diseases, such as atopic dermatitis, psoriasis and acne, through the production of tryptophan metabolites that act as AHR agonists.Type: ApplicationFiled: August 18, 2023Publication date: January 25, 2024Applicant: Seed Health, Inc.Inventors: Sheri Simmons, Tye Jensen, Joseph E. Kovarik
-
Publication number: 20240024154Abstract: A method and system to address the adverse effects on an individual's oral microbiome with the objective of restoring gingival health caused by exposure to sodium lauryl sulfate. Certain embodiments of the present invention facilitate the growth of desired bacteria in a human's mouth to reduce the likelihood of dental caries, halitosis, canker sores, and other oral diseases. Probiotic bacterial, bioactive flavonoid, xylitol and zinc compound compositions, provide effective prevention and treatment options, especially while precluding the use of sodium lauryl sulfate so as to reduce adverse consequences it has on gingival health.Type: ApplicationFiled: August 16, 2023Publication date: January 25, 2024Applicant: SEED HEALTH, INC.Inventors: Sheri Simmons, Tye Jensen, Joseph E. Kovarik
-
Patent number: 11844720Abstract: A method to facilitate the growth of desired bacteria in a human's mouth to reduce the likelihood of dental caries and halitosis and other oral diseases, and for inhibiting oral biofilm formation, gingivitis, periodontitis and halitosis via the employment of one or more probiotic bacterial, bioactive flavonoid, and zinc compound compositions effective in providing prevention and treatment options.Type: GrantFiled: January 31, 2023Date of Patent: December 19, 2023Assignee: Seed Health, Inc.Inventors: Tye Jensen, Joseph E. Kovarik
-
Patent number: 11839632Abstract: Compositions, systems and methods of improving the health of the microbiome of an individual's skin relate to the provision of skin contacting formulations containing beneficial bacteria and other microbe components to foster the growth and maintenance of a healthy skin microbiome. Embodiments include methods for treating an individual suffering from acne vulgaris by topically administering a composition that includes live bacteria selected from the group consisting of L. reuteri, L. johnsonii, L. crispatus, C. acnes, and Nitrosomonas eutropha, that have been modified by using a using a clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR associated protein (Cas) system or a CRISPR from Prevotella and Francisella 1(Cpf1) system to reduce the production of a virulence factor of the bacteria.Type: GrantFiled: March 28, 2023Date of Patent: December 12, 2023Assignee: Seed Health, Inc.Inventors: Tye Jensen, Joseph E. Kovarik
-
Publication number: 20230390343Abstract: A method to reduce the likelihood of a dysbiosis of the vaginal microbiome in an individual employing a probiotic method and composition for maintaining a healthy vaginal microbiome, with particular embodiments including a bacterial formulation of at least two live bacteria selected from the group consisting of L. reuteri, L johnsonii and L. crispatus, and at least one prebiotic having glycogen as a component thereof. The bacterial formulation is administered to an individual's vagina in an amount sufficient for the bacterial formulation to generate an amount of tryptophan metabolites sufficient to act as aryl hydrocarbon receptor (AHR) agonists, thereby reducing inflammation in the individual's vagina. Certain embodiments include increasing the production of SCFAs in the individual's gut microbiome, while reducing the production of SCFAs in the individual's vagina and introducing ammonia oxidizing microorganisms to the individual's vagina.Type: ApplicationFiled: August 10, 2023Publication date: December 7, 2023Applicant: Seed Health, Inc.Inventors: Sheri Simmons, Tye Jensen, Joseph E. Kovarik
-
Patent number: 11833177Abstract: Compositions, systems and methods of improving the health of the microbiome of an individual's skin relate to the provision of skin contacting formulations containing beneficial bacteria, postbiotics, metabolites and other microbe components to foster the growth and maintenance of a healthy skin microbiome. One embodiment includes a topical application of Lactobacillus Crispatus to ameliorate skin barrier damage and inflammation using unique combinations of probiotics, prebiotics, postbiotics, and other skin-beneficial ingredients, effectively treating inflammatory skin diseases, such as atopic dermatitis, psoriasis and acne, through the production of tryptophan metabolites that act as AHR agonists.Type: GrantFiled: April 5, 2023Date of Patent: December 5, 2023Assignee: Seed Health, Inc.Inventors: Sheri Simmons, Tye Jensen, Joseph E. Kovarik
-
Publication number: 20230285473Abstract: Various embodiments of the present invention are directed to the field of treating and preventing osteoporosis, with particular embodiments directed to a method of ameliorating, treating, or preventing osteoporosis in a human subject employing tomatidine, xylitol, rapamycin, etc., as well as modifying an individual’s microbiome to reduce the likelihood of osteoporosis.Type: ApplicationFiled: May 4, 2023Publication date: September 14, 2023Applicant: Seed HealthInventors: Tye Jensen, Joseph E. Kovarik
-
Publication number: 20230241129Abstract: Compositions, systems and methods of improving the health of the microbiome of an individual's skin relate to the provision of skin contacting formulations containing beneficial bacteria, postbiotics, metabolites and other microbe components to foster the growth and maintenance of a healthy skin microbiome. One embodiment includes a topical application of Lactobacillus Crispatus to ameliorate skin barrier damage and inflammation using unique combinations of probiotics, prebiotics, postbiotics, and other skin-beneficial ingredients, effectively treating inflammatory skin diseases, such as atopic dermatitis, psoriasis and acne, through the production of tryptophan metabolites that act as AHR agonists.Type: ApplicationFiled: April 5, 2023Publication date: August 3, 2023Applicant: Seed Health, Inc.Inventors: Sheri Simmons, Tye Jensen, Joseph E. Kovarik
-
Publication number: 20230218682Abstract: Compositions, systems and methods of improving the health of the microbiome of an individual's skin relate to the provision of skin contacting formulations containing beneficial bacteria and other microbe components to foster the growth and maintenance of a healthy skin microbiome. Embodiments include methods for treating an individual suffering from acne valgaris by topically administering a composition that includes live bacteria selected from the group consisting of L reuteri, L johnsonii, L crispatus, C. acnes, and Nitrosomonas eutropha, that have been modified by using a using a clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR associated protein (Cas) system or a CRISPR from Prevotella and Francisella 1 (Cpf1) system to reduce the production of a virulence factor of the bacteria.Type: ApplicationFiled: March 28, 2023Publication date: July 13, 2023Applicant: Seed Health, Inc.Inventors: Tye JENSEN, Joseph E. KOVARIK
-
Publication number: 20230165706Abstract: A method to facilitate the growth of desired bacteria in a human's mouth to reduce the likelihood of dental caries and halitosis and other oral diseases, and for inhibiting oral biofilm formation, gingivitis, periodontitis and halitosis via the employment of one or more probiotic bacterial, bioactive flavonoid, and zinc compound compositions effective in providing prevention and treatment options.Type: ApplicationFiled: January 31, 2023Publication date: June 1, 2023Applicant: SEED HEALTH .INC.Inventors: Tye Jensen, Joseph E Kovarik
-
Patent number: 11260204Abstract: A safety catheter insertion device configured to automatically retract a needle cannula following insertion of a catheter assembly and to inhibit release of the catheter assembly from the safety catheter insertion device until the needle cannula has been retracted for the purpose of inhibiting inadvertent needle sticks. The safety catheter insertion device including an advancement arm slidably coupled to a needle housing assembly and configured to shift between a first position in which a needle cannula traverses through a catheter hub coupling portion of the advancement arm to inhibit release of a catheter assembly, and a second position in which one or more tabs of the advancement arm interact with one or more retention arms of the needle housing assembly to enable a biasing mechanism to shift the needle assembly to a proximal position and enable release of the catheter assembly from the safety catheter insertion device.Type: GrantFiled: April 9, 2019Date of Patent: March 1, 2022Assignee: Smiths Medical ASD, Inc.Inventors: Daniel Casey Johnson, Eric Jason Krause, David J. Goral, Jay T. Breindel, Tye Jensen, Marco Monti